4//SEC Filing
KARBE FRANK 4
Accession 0000950170-25-082458
CIK 0001783183other
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 4:58 PM ET
Size
7.5 KB
Accession
0000950170-25-082458
Insider Transaction Report
Form 4
KARBE FRANK
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-06-03+17,500→ 17,500 totalExercise: $4.95Exp: 2035-06-02→ Common Stock (17,500 underlying) - Award
Common Stock
2025-06-03+10,500→ 67,500 total
Footnotes (2)
- [F1]The Restricted Stock Units ("RSUs") were granted on June 3, 2025, pursuant to the Issuer's Non-Employee Director Compensation Program. 100% of the total number of RSUs granted shall vest on the first to occur of (A) the first anniversary of the date of grant or (B) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuing service on the Board through such vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer.
- [F2]The option was granted pursuant to the Issuer's Non-Employee Director Compensation Program. The option shall vest and/or become exercisable on the first to occur of (A) the first anniversary of the date of grant or (B) the next occurring annual meeting of the Issuer's stockholders, subject to Reporting Person's continuing in service on the Board through such vesting date.
Documents
Issuer
Phathom Pharmaceuticals, Inc.
CIK 0001783183
Entity typeother
Related Parties
1- filerCIK 0001276700
Filing Metadata
- Form type
- 4
- Filed
- Jun 4, 8:00 PM ET
- Accepted
- Jun 5, 4:58 PM ET
- Size
- 7.5 KB